• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹水衰老T细胞与晚期高级别浆液性卵巢癌患者的化疗耐药相关。

Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer.

作者信息

Zhang Jie, He Tianhui, Yin Zhongnan, Shang Chunliang, Xue Lixiang, Guo Hongyan

机构信息

Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing, China.

Cancer Center, Peking University Third Hospital, Beijing, China.

出版信息

Front Oncol. 2022 Jul 7;12:864021. doi: 10.3389/fonc.2022.864021. eCollection 2022.

DOI:10.3389/fonc.2022.864021
PMID:35875098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9301961/
Abstract

Senescent T cells are reported to be increased in patients with cancer and are poor prognostic indicators. However, the distribution of senescent T cells and their correlation with clinical features in high-grade serous ovarian cancer (HGSOC) is unknown. We detected the percentage of senescent T cells in the peripheral blood and ascites of patients with advanced HGSOC (n = 86) at diagnosis by flow cytometry. Compared with healthy donors, patients with HGSOC exhibited an accumulation of CD28CD57 (Tsen) CD8 T cells in the peripheral blood and ascites. The frequency of Tsen CD8 T cells in the peripheral blood was positively correlated with age and pretreatment serum CA125 and increased in patients with large volume ascites, whereas the frequency of Tsen CD8 T cells in ascites was elevated in patients with lymph node metastasis. Patients with Tsen-high in ascites (>19.92%), but not in the peripheral blood, were more likely to be resistant to chemotherapy and had shorter progression-free survival. Tsen CD8 T cells exhibited common senescence features including increased SA-β-gal activity, declines in proliferation, loss of CD27 and gain of KLRG-1, and the production of cytokines. In ascites, the percentage of Tsen CD8 T cells was positively correlated with levels of interleukin-10 and granzyme B. This study suggests the potential of ascitic Tsen CD8 T cells at diagnosis as a prognostic biomarker in HGSOC.

摘要

据报道,癌症患者体内衰老T细胞增多,且是不良预后指标。然而,高级别浆液性卵巢癌(HGSOC)中衰老T细胞的分布及其与临床特征的相关性尚不清楚。我们通过流式细胞术检测了86例晚期HGSOC患者在诊断时外周血和腹水中衰老T细胞的百分比。与健康供体相比,HGSOC患者外周血和腹水中CD28-CD57(Tsen)CD8+ T细胞积聚。外周血中Tsen CD8+ T细胞频率与年龄和治疗前血清CA125呈正相关,且在大量腹水患者中升高,而腹水中Tsen CD8+ T细胞频率在有淋巴结转移的患者中升高。腹水中Tsen高(>19.92%)但外周血中不高的患者更可能对化疗耐药且无进展生存期较短。Tsen CD8+ T细胞表现出常见的衰老特征,包括β-半乳糖苷酶活性增加、增殖能力下降、CD27丢失和KLRG-1增加以及细胞因子产生。在腹水中,Tsen CD8+ T细胞百分比与白细胞介素-10和颗粒酶B水平呈正相关。本研究提示诊断时腹水中的Tsen CD8+ T细胞有可能作为HGSOC的预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/8f5e3283bd96/fonc-12-864021-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/b3bfc8d949b0/fonc-12-864021-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/492b849982be/fonc-12-864021-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/7f57c94b368d/fonc-12-864021-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/37c1b7aaaadf/fonc-12-864021-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/8f5e3283bd96/fonc-12-864021-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/b3bfc8d949b0/fonc-12-864021-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/492b849982be/fonc-12-864021-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/7f57c94b368d/fonc-12-864021-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/37c1b7aaaadf/fonc-12-864021-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58da/9301961/8f5e3283bd96/fonc-12-864021-g005.jpg

相似文献

1
Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer.腹水衰老T细胞与晚期高级别浆液性卵巢癌患者的化疗耐药相关。
Front Oncol. 2022 Jul 7;12:864021. doi: 10.3389/fonc.2022.864021. eCollection 2022.
2
Polyfunctional KLRG-1CD57 Senescent CD4 T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients.多功能 KLRG-1CD57 衰老 CD4 T 细胞浸润肿瘤,并在外周血中从乳腺癌患者中扩增。
Front Immunol. 2021 Jul 27;12:713132. doi: 10.3389/fimmu.2021.713132. eCollection 2021.
3
Serum CA125 and ascites leptin level ratio predicts baseline clinical resistance to first-line platinum-based treatment and poor prognosis in patients with high grade serous ovarian cancer.血清CA125与腹水瘦素水平比值可预测高级别浆液性卵巢癌患者对一线铂类治疗的基线临床耐药性及不良预后。
Am J Cancer Res. 2019 Jan 1;9(1):160-170. eCollection 2019.
4
Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.在高级别浆液性卵巢癌中,表达上皮内淋巴细胞标志物 CD103(αE/β7 整合素)的 CD8+ T 细胞显著升高。
Gynecol Oncol. 2010 Sep;118(3):228-36. doi: 10.1016/j.ygyno.2010.05.016. Epub 2010 Jun 11.
5
Stress hormones are associated with inflammatory cytokines and attenuation of T-cell function in the ascites from patients with high grade serous ovarian cancer.应激激素与高级别浆液性卵巢癌患者腹水中的炎性细胞因子及T细胞功能减弱有关。
Brain Behav Immun Health. 2022 Nov 17;26:100558. doi: 10.1016/j.bbih.2022.100558. eCollection 2022 Dec.
6
[The composition of ascites lymphocytes in high-grade serous ovarian cancer and its correlation with clinical features].[高级别浆液性卵巢癌腹水中淋巴细胞的组成及其与临床特征的相关性]
Zhonghua Yi Xue Za Zhi. 2021 Aug 10;101(30):2375-2381. doi: 10.3760/cma.j.cn112137-20210211-00409.
7
[Clinical significance of ascitic interleukin-7 expression levels in cirrhotic patients complicated with spontaneous bacterial peritonitis].[肝硬化合并自发性细菌性腹膜炎患者腹水中白细胞介素-7表达水平的临床意义]
Zhonghua Gan Zang Bing Za Zhi. 2019 Apr 20;27(4):274-280. doi: 10.3760/cma.j.issn.1007-3418.2019.04.007.
8
CD8CD57 T cells exhibit distinct features in human non-small cell lung cancer.CD8CD57 T 细胞在人类非小细胞肺癌中表现出独特的特征。
J Immunother Cancer. 2020 Jun;8(1). doi: 10.1136/jitc-2020-000639.
9
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?循环中的程序性死亡蛋白1(PD-1)、程序性死亡配体1(PD-L1)、嗜乳脂蛋白3A1(BTN3A1)、泛嗜乳脂蛋白3A(pan-BTN3As)、嗜乳脂蛋白2A1(BTN2A1)和B和T淋巴细胞衰减蛋白(BTLA)水平能否增强晚期高级别浆液性卵巢癌患者中糖类抗原125(CA125)的预后预测能力?
Front Oncol. 2022 Sep 21;12:946319. doi: 10.3389/fonc.2022.946319. eCollection 2022.
10
Single-cell sequencing reveals effects of chemotherapy on the immune landscape and TCR/BCR clonal expansion in a relapsed ovarian cancer patient.单细胞测序揭示化疗对复发性卵巢癌患者免疫图谱和 TCR/BCR 克隆扩增的影响。
Front Immunol. 2022 Sep 28;13:985187. doi: 10.3389/fimmu.2022.985187. eCollection 2022.

引用本文的文献

1
Exhausted and Senescent CD4 T Cells in Peripheral Blood and Their Impact as a Biological Marker for the Diagnosis of Benign and Malignant Ovarian Tumors.外周血中耗竭和衰老的CD4 T细胞及其作为良性和恶性卵巢肿瘤诊断生物学标志物的影响
Diagnostics (Basel). 2025 Aug 12;15(16):2019. doi: 10.3390/diagnostics15162019.
2
Composite score of PD-1 CD8 tumor-infiltrating lymphocytes and CD57 CD8 tumor ascites lymphocytes is associated with prognosis and tumor immune microenvironment of patients with advanced high-grade serous ovarian cancer.PD-1⁺CD8⁺肿瘤浸润淋巴细胞和CD57⁺CD8⁺肿瘤腹水淋巴细胞的综合评分与晚期高级别浆液性卵巢癌患者的预后及肿瘤免疫微环境相关。
Chin J Cancer Res. 2025 Jan 30;37(1):73-89. doi: 10.21147/j.issn.1000-9604.2025.01.06.
3

本文引用的文献

1
Polyfunctional KLRG-1CD57 Senescent CD4 T Cells Infiltrate Tumors and Are Expanded in Peripheral Blood From Breast Cancer Patients.多功能 KLRG-1CD57 衰老 CD4 T 细胞浸润肿瘤,并在外周血中从乳腺癌患者中扩增。
Front Immunol. 2021 Jul 27;12:713132. doi: 10.3389/fimmu.2021.713132. eCollection 2021.
2
Ovarian Cancer Immunotherapy and Personalized Medicine.卵巢癌免疫治疗与个性化医学。
Int J Mol Sci. 2021 Jun 18;22(12):6532. doi: 10.3390/ijms22126532.
3
Aging- and Tumor-Mediated Increase in CD8CD28 T Cells Might Impose a Strong Barrier to Success of Immunotherapy in Glioblastoma.
High-grade serous ovarian cancer (HGSOC) with fallopian tube involvement.高级别浆液性卵巢癌(HGSOC)伴输卵管受累。
Rom J Morphol Embryol. 2024 Apr-Jun;65(2):325-329. doi: 10.47162/RJME.65.2.20.
4
Recent advances in understanding the immune microenvironment in ovarian cancer.卵巢癌免疫微环境研究进展。
Front Immunol. 2024 Jun 5;15:1412328. doi: 10.3389/fimmu.2024.1412328. eCollection 2024.
5
Impacts of cryopreservation on phenotype and functionality of mononuclear cells in peripheral blood and ascites.冷冻保存对外周血和腹水中单核细胞的表型及功能的影响
J Transl Int Med. 2024 Mar 21;12(1):51-63. doi: 10.2478/jtim-2023-0136. eCollection 2024 Feb.
6
[High expression of secretogranin II increases oxaliplatin resistance of colorectal cancer cells].分泌粒蛋白II的高表达增加结肠癌细胞对奥沙利铂的耐药性
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Oct 20;43(10):1657-1664. doi: 10.12122/j.issn.1673-4254.2023.10.02.
7
A Novel Score Using Lymphocyte-to-Monocyte Ratio in Blood and Malignant Body Fluid for Predicting Prognosis of Patients with Advanced Ovarian Cancer.一种利用血液和恶性体液中淋巴细胞与单核细胞比值预测晚期卵巢癌患者预后的新评分系统。
Cancers (Basel). 2023 Apr 17;15(8):2328. doi: 10.3390/cancers15082328.
8
UBE2T regulates epithelial-mesenchymal transition through the PI3K-AKT pathway and plays a carcinogenic role in ovarian cancer.UBE2T 通过 PI3K-AKT 通路调节上皮-间充质转化,在卵巢癌中发挥致癌作用。
J Ovarian Res. 2022 Sep 10;15(1):103. doi: 10.1186/s13048-022-01034-9.
衰老和肿瘤引起的 CD8CD28 T 细胞增加可能对胶质母细胞瘤免疫治疗的成功构成强大障碍。
Immunohorizons. 2021 Jun 8;5(6):395-409. doi: 10.4049/immunohorizons.2100008.
4
Senescent T cells: a potential biomarker and target for cancer therapy.衰老 T 细胞:癌症治疗的潜在生物标志物和靶点。
EBioMedicine. 2021 Jun;68:103409. doi: 10.1016/j.ebiom.2021.103409. Epub 2021 May 25.
5
Impact of age, comorbidity, and treatment characteristics on survival in older women with advanced high grade epithelial ovarian cancer.年龄、合并症和治疗特征对老年晚期高级别上皮性卵巢癌女性生存的影响。
Gynecol Oncol. 2021 Jun;161(3):693-699. doi: 10.1016/j.ygyno.2021.03.008. Epub 2021 Mar 31.
6
Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy.重编程脂质代谢可防止效应 T 细胞衰老,并增强肿瘤免疫治疗。
Sci Transl Med. 2021 Mar 31;13(587). doi: 10.1126/scitranslmed.aaz6314.
7
Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.肿瘤来源的 ILT4 诱导 T 细胞衰老并抑制肿瘤免疫。
J Immunother Cancer. 2021 Mar;9(3). doi: 10.1136/jitc-2020-001536.
8
Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer.上皮性卵巢癌腹水量与临床结局的关系
J Obstet Gynaecol Res. 2021 Apr;47(4):1527-1535. doi: 10.1111/jog.14682. Epub 2021 Jan 27.
9
Immunosenescence: a key player in cancer development.免疫衰老:癌症发展中的关键因素。
J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z.
10
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy.接受单药PD-1/PD-L1抑制剂或铂类化疗的晚期非小细胞肺癌患者循环T细胞免疫衰老
Clin Cancer Res. 2021 Jan 15;27(2):492-503. doi: 10.1158/1078-0432.CCR-20-1420. Epub 2020 Sep 4.